Previous studies have shown that the prevalence of the PNPLA3 rs738409 GG and rs2896019 genotypes was 38.3% and 41.3%, respectively, in Japanese patients with NAFLD, which were higher than those in our study participants.11, 15. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.